Technology Landscape, Trends and Opportunities in the Global Implantable Device Market
Get it in 2 to 4 weeks by ordering today
The material technologies in implantable device has undergone significant change in recent years, with metal t%li%ceramic based implantable device. The rising wave of new material technologies such as metallic and ceramic bi%li%material are creating significant potential for advanced implantable device in various medical platforms due t%li%its favorable mechanical strength, excellent friction-resistance, biocompatibility, and durability.
In implantable device market, various material technologies such as polymer, metal, ceramic, and biologics are used in the orthopedic, dental, facial, breast, and cardiovascular implant applications. Growing elderly population, rise in prevalence of chronic diseases, and rise in incidence of obesity and osteoporosis-related fractures are creating new opportunities for various implantable device technologies.
This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the implantable device market. Some insights are depicted below by a sample figure. For more details on figures, the companies researched, and other objectives/benefits on this research report, please download the report brochure.
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global implantable device technology by application, technology, and region as follows:
Technology Readiness by Material Technology
Competitive Intensity and Regulatory Compliance
Disruption Potential by Material Technology
Trends and Forecasts by Material Technology [$M shipment analysis from 2018 t%li%2030]:
Companies / Ecosystems
Strategic Opportunities by Material Technology
Some of the implantable device companies profiled in this report include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Cardinal Health, Conmed Corporation, Globus Medical, Integra Lifesciences Holdings Corporation, Johnson & Johnson, and LivaNova.
This report answers following 9 key questions:
Q.1 What are some of the most promising and high-growth technology opportunities for the implantable device market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in implantable device market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats t%li%these technologies in implantable device market?
Q.6 What are the latest developments in implantable device technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Wh%li%are the major players in this implantable device market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this implantable device technology space?
The material technologies in implantable device has undergone significant change in recent years, with metal t%li%ceramic based implantable device. The rising wave of new material technologies such as metallic and ceramic bi%li%material are creating significant potential for advanced implantable device in various medical platforms due t%li%its favorable mechanical strength, excellent friction-resistance, biocompatibility, and durability.
In implantable device market, various material technologies such as polymer, metal, ceramic, and biologics are used in the orthopedic, dental, facial, breast, and cardiovascular implant applications. Growing elderly population, rise in prevalence of chronic diseases, and rise in incidence of obesity and osteoporosis-related fractures are creating new opportunities for various implantable device technologies.
This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the implantable device market. Some insights are depicted below by a sample figure. For more details on figures, the companies researched, and other objectives/benefits on this research report, please download the report brochure.
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global implantable device technology by application, technology, and region as follows:
Technology Readiness by Material Technology
Competitive Intensity and Regulatory Compliance
Disruption Potential by Material Technology
Trends and Forecasts by Material Technology [$M shipment analysis from 2018 t%li%2030]:
- Polymer Based
- Metal Based
- Ceramic Based
- Biologics
- Orthopedic Implant
- Polymer Based
- Metal Based
- Ceramic Based
- Biologics
- Dental Implant
- Polymer Based
- Metal Based
- Ceramic Based
- Biologics
- Facial Implant
- Polymer Based
- Metal Based
- Ceramic Based
- Biologics
- Breast Implant
- Polymer Based
- Metal Based
- Ceramic Based
- Biologics
- Cardiovascular Implant
- Polymer Based
- Metal Based
- Ceramic Based
- Biologics
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- Japan
- China
- South Korea
- India
- The Rest of the World
Companies / Ecosystems
Strategic Opportunities by Material Technology
Some of the implantable device companies profiled in this report include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Cardinal Health, Conmed Corporation, Globus Medical, Integra Lifesciences Holdings Corporation, Johnson & Johnson, and LivaNova.
This report answers following 9 key questions:
Q.1 What are some of the most promising and high-growth technology opportunities for the implantable device market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in implantable device market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats t%li%these technologies in implantable device market?
Q.6 What are the latest developments in implantable device technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Wh%li%are the major players in this implantable device market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this implantable device technology space?
1. EXECUTIVE SUMMARY
2. TECHNOLOGY LANDSCAPE
2.1. Technology Background and Evolution
2.2. Technology and Application Mapping
2.3. Supply Chain
3. TECHNOLOGY READINESS
3.1. Technology Commercialization and Readiness
3.2. Drivers and Challenges in Implantable Device Technologies
3.3. Competitive Intensity
3.4. Regulatory Compliance
4. TECHNOLOGY TRENDS AND FORECASTS ANALYSIS FROM 2018-2030
4.1. Implantable Device Opportunity
4.2. Technology Trends (2018-2023) and Forecasts (2024-2030)
4.2.1. Polymer Based
4.2.2. Metal Based
4.2.3. Ceramic Based
4.2.4. Biologics
4.3. Technology Trends (2018-2023) and Forecasts (2024-2030) by Application Segments
4.3.1. Orthopedic Implant by Technology
4.3.1.1. Polymer Based
4.3.1.2. Metal Based
4.3.1.3. Ceramic Based
4.3.1.4. Biologics
4.3.2. Dental Implant by Technology
4.3.2.1. Polymer Based
4.3.2.2. Metal Based
4.3.2.3. Ceramic Based
4.3.2.4. Biologics
4.3.3. Facial Implant by Technology
4.3.3.1. Polymer Based
4.3.3.2. Metal Based
4.3.3.3. Ceramic Based
4.3.3.4. Biologics
4.3.4. Breast Implant by Technology
4.3.4.1. Polymer Based
4.3.4.2. Metal Based
4.3.4.3. Ceramic Based
4.3.4.4. Biologics
4.3.5. Cardiovascular Implant by Technology
4.3.5.1. Polymer Based
4.3.5.2. Metal Based
4.3.5.3. Ceramic Based
4.3.5.4. Biologics
5. TECHNOLOGY OPPORTUNITIES (2018-2030) BY REGION
5.1. Implantable Device Market by Region
5.2. North American Implantable Device Technology Market
5.2.1. United States Implantable Device Technology Market
5.2.2. Canadian Implantable Device Technology Market
5.2.3. Mexican Implantable Device Technology Market
5.3. European Implantable Device Technology Market
5.3.1. The United Kingdom Implantable Device Technology Market
5.3.2. German Automotive Implantable Device Technology Market
5.3.3. French Automotive Implantable Device Technology Market
5.4. APAC Implantable Device Technology Market
5.4.1. Chinese Implantable Device System Technology Market
5.4.2. Japanese Implantable Device System Technology Market
5.4.3. Indian Implantable Device System Technology Market
5.4.4. South Korean Implantable Device Technology Market
5.5. ROW Implantable Device Technology Market
6. LATEST DEVELOPMENTS AND INNOVATIONS IN THE IMPLANTABLE DEVICE TECHNOLOGIES
7. COMPANIES / ECOSYSTEM
7.1. Product Portfolio Analysis
7.2. Market Share Analysis
7.3. Geographical Reach
8. STRATEGIC IMPLICATIONS
8.1. Implications
8.2. Growth Opportunity Analysis
8.2.1. Growth Opportunities for the Implantable Device Market by Material Technology
8.2.2. Growth Opportunities for the Implantable Device Market by Application
8.2.3. Growth Opportunities for the Implantable Device Market by Region
8.3. Emerging Trends in the Implantable Device Market
8.4. Disruption Potential
8.5. Strategic Analysis
8.5.1. New Product Development
8.5.2. Capacity Expansion of the Implantable Device Market
8.5.3. Mergers, Acquisitions, and Joint Ventures in the Implantable Device Market
9. COMPANY PROFILES OF LEADING PLAYERS
9.1. Abbott Laboratories
9.2. Biotronik
9.3. Boston Scientific Corporation
9.4. Cardinal Health
9.5. Conmed Corporation
9.6. Globus Medical
9.7. Integra Lifesciences Holdings Corporation
9.8. Johnson & Johnson
9.9. LivaNova
2. TECHNOLOGY LANDSCAPE
2.1. Technology Background and Evolution
2.2. Technology and Application Mapping
2.3. Supply Chain
3. TECHNOLOGY READINESS
3.1. Technology Commercialization and Readiness
3.2. Drivers and Challenges in Implantable Device Technologies
3.3. Competitive Intensity
3.4. Regulatory Compliance
4. TECHNOLOGY TRENDS AND FORECASTS ANALYSIS FROM 2018-2030
4.1. Implantable Device Opportunity
4.2. Technology Trends (2018-2023) and Forecasts (2024-2030)
4.2.1. Polymer Based
4.2.2. Metal Based
4.2.3. Ceramic Based
4.2.4. Biologics
4.3. Technology Trends (2018-2023) and Forecasts (2024-2030) by Application Segments
4.3.1. Orthopedic Implant by Technology
4.3.1.1. Polymer Based
4.3.1.2. Metal Based
4.3.1.3. Ceramic Based
4.3.1.4. Biologics
4.3.2. Dental Implant by Technology
4.3.2.1. Polymer Based
4.3.2.2. Metal Based
4.3.2.3. Ceramic Based
4.3.2.4. Biologics
4.3.3. Facial Implant by Technology
4.3.3.1. Polymer Based
4.3.3.2. Metal Based
4.3.3.3. Ceramic Based
4.3.3.4. Biologics
4.3.4. Breast Implant by Technology
4.3.4.1. Polymer Based
4.3.4.2. Metal Based
4.3.4.3. Ceramic Based
4.3.4.4. Biologics
4.3.5. Cardiovascular Implant by Technology
4.3.5.1. Polymer Based
4.3.5.2. Metal Based
4.3.5.3. Ceramic Based
4.3.5.4. Biologics
5. TECHNOLOGY OPPORTUNITIES (2018-2030) BY REGION
5.1. Implantable Device Market by Region
5.2. North American Implantable Device Technology Market
5.2.1. United States Implantable Device Technology Market
5.2.2. Canadian Implantable Device Technology Market
5.2.3. Mexican Implantable Device Technology Market
5.3. European Implantable Device Technology Market
5.3.1. The United Kingdom Implantable Device Technology Market
5.3.2. German Automotive Implantable Device Technology Market
5.3.3. French Automotive Implantable Device Technology Market
5.4. APAC Implantable Device Technology Market
5.4.1. Chinese Implantable Device System Technology Market
5.4.2. Japanese Implantable Device System Technology Market
5.4.3. Indian Implantable Device System Technology Market
5.4.4. South Korean Implantable Device Technology Market
5.5. ROW Implantable Device Technology Market
6. LATEST DEVELOPMENTS AND INNOVATIONS IN THE IMPLANTABLE DEVICE TECHNOLOGIES
7. COMPANIES / ECOSYSTEM
7.1. Product Portfolio Analysis
7.2. Market Share Analysis
7.3. Geographical Reach
8. STRATEGIC IMPLICATIONS
8.1. Implications
8.2. Growth Opportunity Analysis
8.2.1. Growth Opportunities for the Implantable Device Market by Material Technology
8.2.2. Growth Opportunities for the Implantable Device Market by Application
8.2.3. Growth Opportunities for the Implantable Device Market by Region
8.3. Emerging Trends in the Implantable Device Market
8.4. Disruption Potential
8.5. Strategic Analysis
8.5.1. New Product Development
8.5.2. Capacity Expansion of the Implantable Device Market
8.5.3. Mergers, Acquisitions, and Joint Ventures in the Implantable Device Market
9. COMPANY PROFILES OF LEADING PLAYERS
9.1. Abbott Laboratories
9.2. Biotronik
9.3. Boston Scientific Corporation
9.4. Cardinal Health
9.5. Conmed Corporation
9.6. Globus Medical
9.7. Integra Lifesciences Holdings Corporation
9.8. Johnson & Johnson
9.9. LivaNova
